Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 2 , Pages 285-291 , April 2008

Androgen deprivation therapy for precancerous lesions of the prostate

  • David Hull, MD (Staff Pathologist)
    • ,
  • David G. Bostwick, MD, MBA (CEO and Medical Director)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +1 804 967 9225; Fax: +1 804 545 1690.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-690X(08)00007-9

doi: 10.1016/j.beem.2008.01.006

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 2 , Pages 285-291 , April 2008

Article Tools

* Image Usage & Resolution